Skip to main content
Pharmaco Vigilance
Search form
Search
Home
Perspectives
Case Reports
Focus on
Columns
News
Links
About us
Contacts
News
April 2022
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe
April 2022
Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy Outcomes
April 2022
Hypersensitivity Reactions to COVID-19 Vaccines—Identify High-Risk Children and Vaccinate the Rest
February 2022
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
February 2022
Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies
February 2022
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021
January 2022
A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination
January 2022
Analysis of COVID-19 Vaccine Type and Adverse Effects Following Vaccination
January 2022
Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA Vaccine
December 2021
New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »
80.211.154.110